Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

RRadiopharm Theranostics Ltd

EconomyAI buildoutMarket MapFundsWatchlist
Log in
R

Radiopharm Theranostics Ltd

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions

News

News

  • Radiopharm Theranostics Achieves Confirmed Durable PartialResponse in Ongoing Phase 1 Trial of RAD204 in Patients withAdvanced Solid Tumors Post-Immunotherapy
    Jul 24, 2026Radiopharm Theranostics
  • Radiopharm Theranostics Announces Positive Phase 2b Trial Resultsof RAD 101 for Diagnosis of Brain Metastases
    Jul 23, 2026Radiopharm Theranostics
  • RAD Presentation July 2026
    Jul 23, 2026Radiopharm Theranostics

    Download presentation

  • Zacks Small-Cap Research 2026
    May 14, 2026Radiopharm Theranostics
  • Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
    Feb 25, 2026Radiopharm Theranostics
  • Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
    Jan 30, 2026Radiopharm Theranostics
  • Zacks Small-Cap Research
    Nov 3, 2025Radiopharm Theranostics
  • Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs
    Oct 20, 2025Radiopharm Theranostics
  • CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025
    Oct 20, 2025Radiopharm Theranostics
  • Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
    Jul 29, 2025Radiopharm Theranostics
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions